Analysts take a look at Koninklijke DSM N.V. (OTCMKTS:RDSMY) having this to say.

March 14, 2018 - By Louis Casey

 Analysts take a look at Koninklijke DSM N.V. (OTCMKTS:RDSMY) having this to say.

Koninklijke DSM N.V. (OTCMKTS:RDSMY) Ratings Coverage

Among 4 analysts covering Koninklijke DSM (OTCMKTS:RDSMY), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Koninklijke DSM had 5 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was upgraded by Bank of America to “Buy” on Wednesday, October 14. The company was upgraded on Thursday, October 1 by Liberum Capital. The stock has “Buy” rating by Berenberg on Thursday, August 6. The firm has “Hold” rating by Liberum Capital given on Monday, November 9. The rating was upgraded by ABN Amro to “Buy” on Thursday, October 8. Below is a list of Koninklijke DSM N.V. (OTCMKTS:RDSMY) latest ratings and price target changes.

The stock decreased 0.08% or $0.02 during the last trading session, reaching $24.82. About 81,820 shares traded or 3.72% up from the average. Koninklijke DSM N.V. (OTCMKTS:RDSMY) has 0.00% since March 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Koninklijke DSM N.V., a science-based company, engages in health, nutrition, and materials businesses worldwide. The company has market cap of $17.59 billion. The firm operates through Nutrition, Materials, Innovation Center, and Corporate Activities divisions. It has a 8.03 P/E ratio. It makes food enzymes, cultures, yeast extracts, savory flavors, hydrocolloids, and other specialty ingredients for the food and beverage industries; and nutritional products, such as vitamins, feed enzymes, carotenoids, minerals, eubiotics, nutritional lipids, UV filters and bi-actives, and other ingredients for the feed, food, pharmaceutical, and personal care industries.

More important recent Koninklijke DSM N.V. (OTCMKTS:RDSMY) news were published by: which released: “Why I Bought Corbion In Order To Continue Investing In The Technology Of TerraVia” on October 17, 2017, also published article titled: “Royal DSM (RDSMY) Q3 2017 Results – Earnings Call Transcript”, published: “Royal DSM’s (RDSMY) CEO Feike Sijbesma on Q4 2016 Results – Earnings Call …” on February 15, 2017. More interesting news about Koninklijke DSM N.V. (OTCMKTS:RDSMY) was released by: and their article: “3.24% Yield From Dutch Specialty Chemical Maker DSM” with publication date: August 19, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: